{
    "paper_id": "f729b8142b6706f75d7ad9bec583b3591d01b996",
    "metadata": {
        "title": "Clinical Characteristics Hospitalized Patients with SARS-Cov-2 and HBV Co- 1 infection 2",
        "authors": [
            {
                "first": "Xiaoping",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Qunqun",
                "middle": [],
                "last": "Jiang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhiyong",
                "middle": [],
                "last": "Ma",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Jiaxin",
                "middle": [],
                "last": "Ling",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Wenjia",
                "middle": [],
                "last": "Hu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Qian",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Cao",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pingzheng",
                "middle": [],
                "last": "Mo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Rongrong",
                "middle": [],
                "last": "Yang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Shicheng",
                "middle": [],
                "last": "Gao",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Xien",
                "middle": [],
                "last": "Gui",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Yong",
                "middle": [],
                "last": "Xiong",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            },
            {
                "first": "Jinlin",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "171 65, No.169, Donghu Road, Wuchang 1 9 District, Wuhan City, Hubei Province, 2 1 Karolinska Institutet, 171 65",
                        "settlement": "Stockholm, Stockholm",
                        "country": "P.R China;, Sweden"
                    }
                },
                "email": ""
            },
            {
                "first": "Yongxi",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Zhongnan Hospital of Wuhan University",
                    "location": {
                        "addrLine": "7 No.169, Donghu Road, Wuchang District",
                        "postCode": "430071",
                        "settlement": "Wuhan"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Severe patients were defined according to the Guideline of the treatment of COVID- ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The treatment was mainly the supportive care (Table 1) . Seventy-four patients were 1 7 9",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 45,
                    "end": 54,
                    "text": "(Table 1)",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "7 8"
        },
        {
            "text": "given antiviral (arbidol, orally, 200 mg, three times per day), and 74 with oxygen 1 8 0 support. Antibiotic therapy, both orally and intravenous, were given as described in 1 8 1 and creatinine. All of these biochemical features were found normal; however, the 1 9 1 level of total bilirubin was higher in patients with HBV infection (p=0.0178, Table 2 ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 346,
                    "end": 353,
                    "text": "Table 2",
                    "ref_id": "TABREF6"
                }
            ],
            "section": "7 8"
        },
        {
            "text": "The blood counts of the patients with or without HBV infection showed lymphopenia 1 9 3 (< 1.3 \u00d710 9 /L).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "9 2"
        },
        {
            "text": "1 9 4 1 9 5",
            "cite_spans": [],
            "ref_spans": [],
            "section": "9 2"
        },
        {
            "text": "Hepatitis B serological markers of COVID-19 patients with HBV infection 1 9 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "9 2"
        },
        {
            "text": "The copyright holder for this preprint this version posted March 27, 2020 . . https://doi.org/10.1101 /2020 Fifteen COVID-19 patients were examined to be HBsAg positive (5 females and 10 1 9 7 males). The data of anti-HBsAg, HBeAg, anti-HBeAg and anti-HBcAg were 1 9 8 available for 11 patients with ten patients HBeAg negtive and one positive. The value 1 9 9 of HBV-DNA was collected from 13 patients. The HBV-DNA level of 10 patients are 2 0 0 more than 20 IU/ml (Table S1 ). showed higher mortality rate compared to those COVID-19 patients without HBV 2 1 0 infection (13.3%vs 2.8%, Table 2 ). cause patients severe respiratory symptoms and even leads to death with average 2 1 5 mortality rate of 3.4% (according to the data reported from WHO) though most cases 2 1 6 of COVID-19 are acute and resolve fast. Liver damage has been identified in around 2 1 7 60% of patients suffering from SARS and viral RNA was detected by RT-PCR in 2 1 8 liver tissue(10), which providing the evidence that SARS-CoV involved in live injure.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 73,
                    "text": "March 27, 2020",
                    "ref_id": null
                },
                {
                    "start": 74,
                    "end": 101,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 102,
                    "end": 107,
                    "text": "/2020",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 466,
                    "end": 475,
                    "text": "(Table S1",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 587,
                    "end": 594,
                    "text": "Table 2",
                    "ref_id": "TABREF6"
                }
            ],
            "section": "9 2"
        },
        {
            "text": "Liver impairment has been also reported in MERS patients(11). According to the 2 2 0 clinical reports from different centers with large scale of COVID-19 cases, SARS-",
            "cite_spans": [],
            "ref_spans": [],
            "section": "1 9"
        },
        {
            "text": "CoV-2 has been found to be associated with damage or dysfunction of liver tissue(9, 2 2 2 12-18) and about 14% -53% COVID-19 cases showed liver function damage with 2 2 3 abnormal level of alanine aminotransferase (ALT) and aspartate aminotransferase 2 2 4 (AST). Our study is in line with previous observations. We found in COVID-19 cases 2 2 5 without HBV infection that about 50.9% (55/108) patients have the dysfunction of 2 2 6 liver symptoms by measuring the level of ALT, AST, total bilirubin (TBIL), gamma-2 2 7 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "1"
        },
        {
            "text": "The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.23.20040733 doi: medRxiv preprint glutamyltransferase (GGT), and alkaline phosphatase (ALP) during the disease 2 2 8 progress. In our enrolled cases, we also discovered that there is higher incidence of 2 2 9 abnormal liver function (81.8%, 27/33) in severe COVID-19 patients than did in mild 2 3 0 cases(43.3%, 39/90, data not shown), which agrees with the study that lower 2 3 1 incidence of AST abnormality was found in the cases diagnosed by CT scan on the 2 3 2 subclinical stage than in the COVID-19 patients who were confirmed after onset of 2 3 3 symptom(15). Therefore, liver function could be considered as one factor to indicate 2 3 4 the progress of COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "According to other study from 1099 cases, around 23.7% of confirmed COVID-19 2 3 6 patients have at least one comorbidity(13). Among these pre-existing chronic diseases, 2 3 7 abnormal liver function is one of most common features in COVID-19 patients and 2 3 8 severe patients are more likely to have HBV infection. In our research, about one out 2 3 9 of five (21.8%) COVID-19 severe patients were found to coinfect with HBV infection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "3 5"
        },
        {
            "text": "It has been suggested that liver impairment in COVID-19 patients could be due to the pointed out that as high as around 50% of HBV patients were identified as severe 2 4 5 COVID-19 cases. It is more likely that HBV patients will suffer from more severe 2 4 6 situation during the disease progress when were encountered with SARS-CoV-2 2 4 7 infection. In our enrolled cases, two patients with SARS-CoV and HBV coinfection 2 4 8 died on admission. One patient died from severe liver disease, haptic sclerosis. And 2 4 9 the other died from intestinal hemorrhage, which seems to be associated the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "4 0"
        },
        {
            "text": "The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10. 1101 /2020 In conclusion, by respectively analyzing the patients with coinfection of SARS-CoV-2 6 0 2 and HBV, we found that the patients with pre-existing HBV infection will be much 2 6 1 more vulnerable to SARS-CoV-2 infection. During the pandemic of SARS-CoV-2 2 6 2 infection, HBV patients should be given the specific protection. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 101,
                    "text": "1101",
                    "ref_id": null
                },
                {
                    "start": 102,
                    "end": 107,
                    "text": "/2020",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted March 27, 2020. . ,  Y  a  o  H  ,  T  s  a  n  g  T  Y  ,  C  h  o  w  T  C  ,  Y  e  u  n  g  Y  C  ,  C  h  o  i  K  W  ,  e  t  a  l  .  2  9  8  S  A  R  S  -a  s  s  o  c  i  a  t  e  d  v  i  r  a  l  h  e  p  a  t  i  t  i  s  c  a  u  s  e  d  b  y  a  n  o  v  e  l  c  o  r  o  n  a  v  i  r  u  s  :  r  e  p  o  r  t  o  f  t  h  r  e  e  c  a  s  e  s  .  2  9  9  H  e  p  a  t  o  l  o  g  y  2  0  0  4  ;  3  9  :  3  0  2  -3  1  0  .  3  0  0  1  1  .  A  l  s  a  a  d  K  O  ,  H  a  j  e  e  r  A  H  ,  A  l  B  a  l  w  i  M  ,  A  l  M  o  a  i  q  e  l  M  ,  A  l  O  u  d  a  h  N  ,  A  l  A  j  l  a  n  A  ,  3  0  1  A  l  J  o  h  a  n  i  S  ,  e  t  a  l  .  H  i  s  t  o  p  a  t  h  o  l  o  g  y  o  f  M  i  d  d  l  e  E  a  s  t  r  e  s  p  i  r  a  t  o  r  y  s  y  n  d  r  o  m  e  c  o  r  o  n  o  v  i  r  u  s  3  0  2 ( . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 77,
                    "end": 929,
                    "text": ",  Y  a  o  H  ,  T  s  a  n  g  T  Y  ,  C  h  o  w  T  C  ,  Y  e  u  n  g  Y  C  ,  C  h  o  i  K  W  ,  e  t  a  l  .  2  9  8  S  A  R  S  -a  s  s  o  c  i  a  t  e  d  v  i  r  a  l  h  e  p  a  t  i  t  i  s  c  a  u  s  e  d  b  y  a  n  o  v  e  l  c  o  r  o  n  a  v  i  r  u  s  :  r  e  p  o  r  t  o  f  t  h  r  e  e  c  a  s  e  s  .  2  9  9  H  e  p  a  t  o  l  o  g  y  2  0  0  4  ;  3  9  :  3  0  2  -3  1  0  .  3  0  0  1  1  .  A  l  s  a  a  d  K  O  ,  H  a  j  e  e  r  A  H  ,  A  l  B  a  l  w  i  M  ,  A  l  M  o  a  i  q  e  l  M  ,  A  l  O  u  d  a  h  N  ,  A  l  A  j  l  a  n  A  ,  3  0  1  A  l  J  o  h  a  n  i  S  ,  e  t  a  l  .  H  i  s  t  o  p  a  t  h  o  l  o  g  y  o  f  M  i  d  d  l  e  E  a  s  t  r  e  s  p  i  r  a  t  o  r  y  s  y  n  d  r  o  m  e  c  o  r  o  n  o  v  i  r  u  s  3  0  2",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted March 27, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Total bilirubin",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "5--21",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Alkaline phosphatase (U/L)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "infection were discharged from the hospital according to the guideline.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Resemble to the other two coronaviruses, SARS-CoV and MERS, SARS-CoV-",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "18). To detect the viral RNA and viral particles from liver biopsies of 2 4 3 COVID-19 patients will be helpful to elucidate if virus infect liver tissue.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "effects of SARS-CoV-2 infection on active HBV replication and live 2 5 8 impairment at different time points for the HBV patients in different phases.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "manuscript. The authors declared no competing interests.",
            "latex": null,
            "type": "figure"
        },
        "TABREF1": {
            "text": "Sixty-one patients received corticosteroids to suppress an excessive inflammatory activation. There is no significant difference of treatment betweenThe biochemical tests included measuring the level of alanine aminotransferase,",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": ". https://doi.org/10.1101/2020.03.Table 1. Demographics, baseline characteristics, treatment and clinical outcomes of 123 COVID-19 patients with or without HBV infection BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version postedMarch 27, 2020.  .  https://doi.org/10.1101/2020",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Laboratory results of 123 COVID-19 patients with or without HBV infection Table S1. Hepatitis B serological markers of fifteen COVID-19 patients with HBV Demographics Hepatitis B virus serological markers",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}